−£183k
vs Jun 2024Active10835544Private limited companyWarrington
DARESBURY PROTEINS LTD.
Significant control: Jennet Beesley (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Daresbury Proteins Ltd.: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Daresbury Proteins Ltd. sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
DARESBURY PROTEINS LTD. is an active private limited company (company number 10835544) incorporated on 26 June 2017, registered in Warrington. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest abridged accounts cover the period ending 30 June 2025, showing net assets of −£183k and cash of £43k, with 4 employees on average. As abridged accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 21% on the prior period (−£151k).
Peer position · net assets
By net assets it sits in the bottom quarter of 138 comparable companies in Manchester (median £436, upper quartile £124k).
02
Ownership and control
- Dr Jennet Beesley
- owns 25–50% of shares
- Mr Mark Antony Beesley
- owns 25–50% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 26 June 20179 yrs ago
- Next accounts due
- 30 March 2027in 154 days
- Confirmation statement due
- 10 July 2027in 256 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Unaudited Abridged
- Size band
- MicroCompanies Act thresholds
05
Financials
£43k
−53%vs Jun 2024Not disclosed
4
−20%vs Jun 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 June 2025 | −£183k | £43k | £57k | — | — | — | 4 |
| 30 June 2024 | −£151k | £92k | £15k | — | — | — | 5 |
Cash per employee£11kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-182,529 at 30 June 2025
- Incorporated five or more years agoIncorporated 26 June 2017
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 256 days
- Next accounts duein 154 days
- Accounts period endNet liabilities £183k · abridged accounts
- Accounts period endNet liabilities £151k · abridged accounts
- Incorporated
08
Similar companies in Manchester
- HAIRCLONE RESEARCH LIMITEDManchester · inc. Jun 2017
- HAIRCLONE CELL THERAPY LIMITEDManchester · inc. Jun 2017
- HAIRCLONE CELL BANKING LIMITEDManchester · inc. Aug 2017
- NEOPHORE LIMITEDAltrincham · inc. May 2017
- EVARISTE LTDAltrincham · inc. Oct 2017
- EPISTEM LIMITEDManchester · inc. Oct 2017
All companies incorporated on 26 June 2017 · in Jun 2017.
09
Reminders for DARESBURY PROTEINS LTD.
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.